UK 1997 [20]
|
3.3 / week / 100,000 catchment area population ~5 people per week
|
64% (nurses)
|
1:1
|
Diazepam
|
Most frequent
|
27 (10–80)
| |
1 hypotention
|
| | | |
Haloperidol
|
(exact data not presented)
|
22 (10–60)
|
26%
|
1 cardiorespiratory arrest (60 mg haloperidol + 80 mg DZ)
|
| | | |
Chlorpromazine
| |
162 (50–400)
| |
1 tachycardia, 1 hypotention
|
| | | |
Droperidol
| |
14 (10–20)
| | |
| | | |
Paraldehyde
| | | |
1 respiratory distress
|
| | | |
Amytal
| | | | |
| | | |
Lorazepam
| | | | |
| | | |
Nitrazepam
|
Least frequent
| | | |
France 1999 [18]
|
5.6 / 1000 contacts
|
86% (nurses)
|
0:80
|
Loxapine
|
80%
|
200 mg
| |
2 with acute dystonia
|
| | | |
Droperidol
|
5%
| | | |
| | | |
Chlorazepate
|
5%
| | | |
| | | |
Cyamemazine
|
< 2%
| |
6%
|
Mostly people with substance abuse
|
| | | |
Diazepam
| | | | |
| | | |
Sultopride
| | | | |
| | | |
Meprobamate
| | | | |
Brazil 2000 [13]
|
2.1 / week / 100,000 catchment area population ~74 people per week
|
Majority (restraints and nurses)
|
0:74
|
Haloperidol + promethazine
|
61%
|
5 (2.5–10) + 50 (25–100)
|
0%
| |
| | | |
Haloperidol + Promethazine + Diazepam
|
15%
|
5 (2.5–10) + 50 (25–100) + 10
| | |
| | | |
Diazepam
|
9%
|
10
| | |
| | | |
Haloperidol + Promethazine + Chlorpromazine
|
7%
|
5 + 50 + 25
| | |
| | | |
Chlorpromazine + Diazepam + Promethazine
|
1%
|
25 + 10
| | |
| | | |
Chlorpromazine + Promethanzine
|
1%
|
25 + 50
| | |
| | | |
Chlorpromazine
|
1%
|
25
| | |
| | | |
Diazepam + Promethazine
|
1%
|
10 + 5
| | |
| | | |
Haloperidol + Diazepam
|
1%
|
5 + 10
| | |
| | | |
Promethazine
|
1%
|
50
| | |